LIVER DISEASE MARKERS
    2.
    发明申请
    LIVER DISEASE MARKERS 审中-公开
    肝病患者

    公开(公告)号:US20130225428A1

    公开(公告)日:2013-08-29

    申请号:US13691170

    申请日:2012-11-30

    IPC分类号: C12Q1/68 G01N33/68

    CPC分类号: C12Q1/6876 G01N33/6893

    摘要: New markers for diseased liver conditions have been identified. A combination of protein C (PROC) and retinol binding protein 4 (RBP4) in blood are biomarkers to distinguish patients at different stages of hepatic fibrosis due, for example, to chronic infection with hepatitis C virus (HCV). Also, alpha-1-B glycoprotein (A1BG), complement factor H (CFH) and insulin-like growth factor binding protein acid labile subunit (IGFALS) distinguish subjects with chronic or acute liver conditions such as hepatitis infection or liver fibrosis from healthy controls.

    摘要翻译: 已经确定了患病肝脏疾病的新标志物。 血液中蛋白C(PROC)和视黄醇结合蛋白4(RBP4)的组合是生物标志物,以区分肝纤维化的不同阶段的患者,例如由于丙型肝炎病毒(HCV)的慢性感染。 此外,α-1-B糖蛋白(A1BG),补体因子H(CFH)和胰岛素样生长因子结合蛋白酸不稳定亚基(IGFALS)区分来自健康对照的慢性或急性肝病例如肝炎感染或肝纤维化的受试者 。